Ex vivo intestinal permeability assay (X-IPA) for tracking barrier function dynamics

The intestinal epithelial barrier facilitates homeostatic host-microbiota interactions and immunological tolerance. However, mechanistic dissections of barrier dynamics following luminal stimulation pose a substantial challenge. Here, we describe an ex vivo intestinal permeability assay, X-IPA, for quantitative analysis of gut permeability dynamics at the whole-tissue level. We demonstrate that specific gut microbes and metabolites induce rapid, dose-dependent increases to gut permeability, thus providing a powerful approach for precise investigation of barrier functions.

Automated summary

In this study, the researchers developed an ex vivo intestinal permeability assay, X-IPA, for quantitative analysis of gut permeability dynamics. They found that specific gut microbes and metabolites can rapidly and dose-dependently increase gut permeability, providing a powerful tool for investigating barrier functions.